Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Entasis Therapeutics Inc...

    NASDAQ: ETTX · Real-Time Price · USD
    2.19
    -0.01 (-0.45%)
    At close: Jul 08, 2022, 10:00 PM

    Entasis Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2021
    Period Ending Dec 31, 2021
    Revenue
    		 n/a
    Cost of Revenue
    		 n/a
    Gross Profit
    		 n/a
    Operating Income
    		 -47.14M
    Interest Income
    		 13K
    Pretax Income
    		 -47.14M
    Net Income
    		 -47.14M
    Selling & General & Admin
    		 15.21M
    Research & Development
    		 37.1M
    Other Expenses
    		 n/a
    Operating Expenses
    		 52.32M
    Interest Expense
    		 n/a
    Selling & Marketing Expenses
    		 n/a
    Cost & Expenses
    		 52.32M
    Income Tax Expense
    		 n/a
    Shares Outstanding (Basic)
    		 47.31M
    Shares Outstanding (Diluted)
    		 47.31M
    EPS (Basic)
    		 -1
    EPS (Diluted)
    		 -1
    EBITDA
    		 -47.04M
    EBIT
    		 -47.14M
    Depreciation & Amortization
    		 104K

    Add to Watchlist